Objetivo Patient availability is one of the key elements associated with the successful execution of rare disease drug trials, and at thesame time a major bottleneck that increases drug development time and cost. Patient recruitment is responsible for 25-30% of the total costs of a clinical trial, for adding substantially to the duration of a trial, and for the failure of 1 in 3 Phase 3 clinicaltrials. Decodeon aims to transform this bottleneck into a major node in the value chain by developing and deploying structured and efficient patient registries for pharma companies and Contract Research Organisations (CROs). In doing so, Decodeon aims to overhaul this major inefficiency in clinical trial management, while tapping into an unexplored market worth €2.5 billion.Currently, big pharma tenders clinical trials to CROs, who perform a trial for e.g. a lump sum. Decodeon will provide CROs with rare disease patients who have pre-consented with inclusion in a clinical trial, filtered based on the specific inclusion/exclusion criteria of the trial, and at the required numbers. As a consequence, CRO efficiency will increase, through lowering the time required for patient recruitment and the associated costs. Support for our novel platform is demonstrated through letters of support, annexed to this proposal. Ámbito científico medical and health sciencesclinical medicinepsychiatrysleep disordersmedical and health sciencesbasic medicinepharmacology and pharmacydrug discoverymedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugssocial scienceseconomics and businessbusiness and managementbusiness models Programa(s) H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) Main Programme H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Tema(s) SMEInst-01-2016-2017 - Open Disruptive Innovation Scheme Convocatoria de propuestas H2020-SMEInst-2016-2017 Consulte otros proyectos de esta convocatoria Convocatoria de subcontratación H2020-SMEINST-1-2016-2017 Régimen de financiación SME-1 - SME instrument phase 1 Coordinador DECODEON BV Aportación neta de la UEn € 50 000,00 Dirección BOOTHSTRAAT 5 3512 BT UTRECHT Países Bajos Ver en el mapa Pyme Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención. Sí Región West-Nederland Utrecht Utrecht Tipo de actividad Private for-profit entities (excluding Higher or Secondary Education Establishments) Enlaces Contactar con la organización Opens in new window Participación en los programas de I+D de la UE Opens in new window Red de colaboración de HORIZON Opens in new window Coste total € 71 429,00